Literature DB >> 25777161

Influenza virus aggravates the ox-LDL-induced apoptosis of human endothelial cells via promoting p53 signaling.

Jing Suo1, Long Zhao, Jian Wang, Zhichuan Zhu, Huafeng Zhang, Rong Gao.   

Abstract

Oxidized low-density lipoprotein (ox-LDL) is well recognized to play a key role in the development of atherosclerosis. And influenza virus infection has been also recognized to promote the atherosclerosis onset and progressing. However, little is known about the mechanism into it. In present study, we investigated the infection of A/Porto Rico/8/1934 (H1N1) (PR8) influenza virus in human endothelial Eahy926 cells, and determined the induction of apoptosis by the virus infection in the cell. Then we investigated the apoptosis induced by ox-LDL in Eahy926 cells, determined the influence of influenza virus infection on the ox-LDL-induced apoptosis in Eahy926 cells. Results demonstrated that PR8 virus infected human endothelial Eahy926 cells, forming plaques and replicated efficiently in the cell. And the virus infection promoted apoptosis in the cell, upregulated cytchrome c release, activated caspase 3. And what's more, we found that combined PR8 virus infection and ox-LDL treatment promoted higher level of apoptosis and higher level of the activation of apoptosis-associated molecules. Further examination indicated that the p53 signaling was more significantly promoted by both treatments. Therefore, present study confirmed that influenza virus aggravated the ox-LDL-induced apoptosis of human endothelial Eahy926 cells via promoting p53 signaling.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Apoptosis; endothelial Eahy926 cells; influenza virus; ox-LDL; p53

Mesh:

Substances:

Year:  2015        PMID: 25777161     DOI: 10.1002/jmv.24166

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  3 in total

1.  Synergistic enhancement of matrix metalloproteinase-9 expression and pro-inflammatory cytokines by influenza virus infection and oxidized-LDL treatment in human endothelial cells.

Authors:  Yun Wu; He Huang
Journal:  Exp Ther Med       Date:  2017-09-01       Impact factor: 2.447

Review 2.  Proatherogenic Sialidases and Desialylated Lipoproteins: 35 Years of Research and Current State from Bench to Bedside.

Authors:  Alexandre Mezentsev; Evgeny Bezsonov; Dmitry Kashirskikh; Mirza S Baig; Ali H Eid; Alexander Orekhov
Journal:  Biomedicines       Date:  2021-05-25

Review 3.  Immune Mechanisms in Cardiovascular Diseases Associated With Viral Infection.

Authors:  Radha Gopal; Michael A Marinelli; John F Alcorn
Journal:  Front Immunol       Date:  2020-10-22       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.